NMD-VCell Neuromuscular Virtual Cell Research Platform Module: Data · Evidence → perturbation → experiment → outcome NMD = neuromuscular disorders

Release 2026.08DMD context observedDMD candidate-conditioned prediction not yet eligible

View scientific status
Evidence freeze: 3 August 2026 Resource: v1.2.0-measured-dmd-evidence Schema: 1.1 Open release status →

← Dataset Registry

Dataset Card · nmd-vcell-dataset-registry-record/1.0

DMD-locus CRISPR-correction transcript reference

A versioned, citable account of what was measured, which task this object may support and which prediction claims remain blocked.

01SourceGSE272233
02Typed contextDMD-locus correction reference
03Qualified roleCheck disease-correction direction and context
04DMD prediction outcomeNot qualified

What it proves

DMD-locus correction changes disease-context transcript programs in patient-derived/corrected models.

bulk sample · Bulk RNA expression and correction contrasts

What it cannot prove

It cannot isolate a displayed candidate's perturbation effect because those candidates were not perturbed.

Dataset value is task-specific; no Dataset Card alone is evidence of candidate efficacy, patient response or clinical utility.

Best model use

Use as orthogonal DMD directionality and disease-correction context, not as candidate-training truth.

Check disease-correction direction and context

Next experiment handoff

Use the corrected-vs-DMD contrast to choose endpoints for a separate candidate perturbation study.

Candidate transcripts are observed but candidates were not perturbed

Identity & access

Source receipt

Accession
GSE272233
Licence
Source repository and publication terms apply; verify at accession
Source verification
required
Stable page
/resource/dataset/gse272233/

Biological context

What it represents

Disease / context
Duchenne muscular dystrophy
Species
Homo sapiens
Tissue / model
DMD-locus correction reference
Cell type
Patient-derived and corrected cellular models
Donor metadata
grouped sample identities available

Measurement design

What was measured

Modality
bulk RNA expression
Observation unit
bulk sample
Size
21 samples; 3 per reported group
Count state
not single cell
Endpoint
Bulk RNA expression and correction contrasts

Perturbation design

Intervention contract

Perturbation
DMD-locus correction
Dose
DMD-locus correction; candidate perturbation absent
Timepoints
Study endpoint
Direct DMD candidate outcome
No

Replication & provenance

Receipt completeness

Biological replicates
3 per reported group
Technical replicates
source publication required
Batch / platform
source publication required
Raw hashes
upstream accession required
Processed hashes
processed matrix checksummed
Analysis hashes
derived tables in resource manifest

Benchmark partition

Permitted computational use

Orthogonal disease-correction reference

  • disease_correction_context_only
Leakage grouping
orthogonal reference no candidate training
Donor holdout
No
Disease-state holdout
No
Prospective holdout
No

Readiness decision

Check disease-correction direction and context

Candidate transcripts are observed but candidates were not perturbed

Associated resources

Continue through the governed loop.